Erica McAuliffe
Gillian Lieberman, MD
Chemical
• Fat protons and water p
resonance frequencies.
• At a known time interva
phase, and their signals
• By timing images based
can determine the fat co
Shift MRI
protons have different
.
al, the protons are out-of-
s cancel out.
d upon this interval, we
ontent of a certain tissue.
26
Erica McAuliffe
Gillian Lieberman, MD
Chemical Shift MRI
IN-PHASE
OUT-OF-PHASE
P. D. Peppercorn, A. B. Grossman & R. H. Reznek (1998). Clini
I – Example of Mets
No loss of signal intensity
indicates no intracellular
fat.
27
ical Endocrinology 48 (4), 379-388.
Erica McAuliffe Patient
Gillian Lieberman, MD
Chemical Shift MR
IN-PHASE
Loss of signal intensity indicate
t W.W.:
RI of R adrenal mass
OUT-OF-PHASE
es presence of intracellular lipid.
28
Erica McAuliffe
Gillian Lieberman, MD
Patient W
Chemical Shift MRI
IN-PHASE
Signal intensity decreases, ex
W.W.:
of L adrenal mass
OUT-OF-PHASE
xcept for small central focus.
29
Erica McAuliffe
Gillian Lieberman, MD
Our Patient
• Uncertainty persisted af
• Percutaneous biopsy do
• Pathology revealed ben
• Left upper lobectomy pe
revealed adenocarcinom
• Right nephrectomy and
performed --> revealed
and… R adrenal myeloli
W.W., cont.
fter CT and MRI.
one of L adrenal gland.
nign L adrenal adenoma.
erformed --> pathology
ma of lung.
adrenalectomy
renal cell carcinoma
ipoma.
30
Erica McAuliffe
Gillian Lieberman, MD
Adrenal Myelolipo
• Benign tumors composed of
adipose and hematopoietic
tissue.
• Radiographic features: F
– Macroscopic fat (low
attenuation)
– May enhance with
contrast administration
– 20% calcify
• No treatment required.
omas: Patient #3
From Udelsman R. and EK Fishman. Endocrinology and Metabolism
Clinics of North America. 29(1), March 2000.
31
Erica McAuliffe
Gillian Lieberman, MD
Algorithm for incide
Adrenal m
Not hyperfunctioning Biochemi
> 3cm Size < 3cm
Biopsy EITHER
or surgery
Non-contrast CT
CT attenuation value
HU < 10 HU > 10
Benign adenoma Chemical-shift MRI
or biopsy
From Sohaib, SAA and RH Reznek. BJU International (2000),
ental adrenal mass
mass
istry Functioning
Surgery
Chemical-Shift MRI
Signal intensity
Loss No loss
Benign adenoma Biopsy or
surgery
86 Suppl.1, 95-110.
32
Erica McAuliffe
Gillian Lieberman, MD
Differential D
Adrenal En
• BENIGN
– Adenoma - functional
– Adenoma - nonfunctional
– Adrenal hyperplasia
– Pheochromocytoma (90%)
– Myelolipoma
• MALIGNANT
– 1° adrenal carcinoma
– Metastasis
– Ganglioneuroma
– Neuroblastoma
Diagnosis of
nlargement
• OTHER
– Cyst
– Hematoma/Hemorrhage
– Infection
33
Erica McAuliffe
Gillian Lieberman, MD
Refere
• Bergman, RA, AK Afifi, PM Heidger, Univ
http://www.vh.org/Providers/Textbooks/Microsc
• Busick, NP, PC Fretz, JR Galvin, MW Pe
http://www.vh.org/Providers/Textbooks/LungTu
ets.html
• Cotran et al., ed.: Robbins Pathologic Ba
Company, 1999.
• Kaplan, NM. The adrenal incidentaloma.
• Netter, Frank. Atlas of Human Anatomy. 2
• Pender, SM, GW Boland, and MJ Lee. T
mass: an imaging algorithm for character
• Peppercorn, PD, AB Grossman, and RH
adrenal masses. Clinical Endocrinology (
• Sohaib, SAA and RH Reznek. Adrenal im
95-110.
• Udelsman, R. and EK Fishman. Radiolog
Metabolism Clinics of North America (200
• Weissleder. Primer of Diagnostic Imaging
ences
versity of Iowa, 2001:
copicAnatomy/Section15/Plate15293.html
eterson, and CE Platz, Univ. of Iowa, 2000:
umors/CaseStudies/Patient004/Text/CTCompAdrenalM
asis of Disease, 6th ed., W. B. Saunders
. UpToDate, online 10.1. 2002.
2nd edition. Novartis: 1997.
The incidental nonhyperfunctioning adrenal
rization. Clinical Radiology (1998), 53: 796-804
Reznek. Imaging of incidentally discovered
(1998), 48: 379-388.
maging. BJU International (2000), 86 Suppl.1:
gy of the adrenal. Endocrinology and
00), 29(1): 27-42.
g. Mosby, Inc., 1996.
34
Erica McAuliffe
Gillian Lieberman, MD
Acknowle
• Damon Soiero, MD
• Haldon Bryor, MD
• Jonathan Kruskal, M
• Gillian Lieberman, M
• Pamela Lepkowski
• Webmasters Larry B
D’amour
edgments
MD
MD
Barbaras and Cara Lyn
35